These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20347570)

  • 1. Gene expression analysis on the liver of cholestyramine-treated type 2 diabetic model mice.
    Matsumoto K; Yokoyama S
    Biomed Pharmacother; 2010 Jul; 64(6):373-8. PubMed ID: 20347570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cholesterol, cholic acid and cholestyramine administration on the intestinal mRNA expressions related to cholesterol and bile acid metabolism in the rat.
    Kamisako T; Ogawa H; Yamamoto K
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1832-7. PubMed ID: 17498222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of nuclear receptors in the up-regulation of hepatic cholesterol 7alpha-hydroxylase by cholestyramine in rats.
    Shibata S; Hayakawa K; Egashira Y; Sanada H
    Life Sci; 2007 Jan; 80(6):546-53. PubMed ID: 17107691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid binding resin improves hepatic insulin sensitivity by reducing cholesterol but not triglyceride levels in the liver.
    Tagawa H; Irie J; Itoh A; Kusumoto Y; Kato M; Kobayashi N; Tanaka K; Morinaga R; Fujita M; Nakajima Y; Morimoto K; Sugizaki T; Kawano Y; Yamada S; Kawai T; Watanabe M; Itoh H
    Diabetes Res Clin Pract; 2015 Jul; 109(1):85-94. PubMed ID: 25981325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acids and lipoprotein metabolism: effects of cholestyramine and chenodeoxycholic acid on human hepatic mRNA expression.
    Nilsson LM; Abrahamsson A; Sahlin S; Gustafsson U; Angelin B; Parini P; Einarsson C
    Biochem Biophys Res Commun; 2007 Jun; 357(3):707-11. PubMed ID: 17448444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
    Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
    Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
    Kobayashi M; Ikegami H; Fujisawa T; Nojima K; Kawabata Y; Noso S; Babaya N; Itoi-Babaya M; Yamaji K; Hiromine Y; Shibata M; Ogihara T
    Diabetes; 2007 Jan; 56(1):239-47. PubMed ID: 17192488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The messenger RNA profiles in liver, hypothalamus, white adipose tissue, and skeletal muscle of female Zucker diabetic fatty rats after topiramate treatment.
    Liang Y; She P; Wang X; Demarest K
    Metabolism; 2006 Oct; 55(10):1411-9. PubMed ID: 16979414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
    Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
    Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of sterol synthesis in the liver and extrahepatic tissues of the SHR/N-corpulent rat, an animal with hyperlipidemia and insulin-independent diabetes.
    Turley SD; Hansen CT
    J Lipid Res; 1986 May; 27(5):486-96. PubMed ID: 3525721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grape Seed Procyanidins and Cholestyramine Differentially Alter Bile Acid and Cholesterol Homeostatic Gene Expression in Mouse Intestine and Liver.
    Heidker RM; Caiozzi GC; Ricketts ML
    PLoS One; 2016; 11(4):e0154305. PubMed ID: 27111442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some effects of chitosan on liver function in the rat.
    LeHoux JG; Grondin F
    Endocrinology; 1993 Mar; 132(3):1078-84. PubMed ID: 7679967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bile acid sequestration on hepatic steatosis in obese mice.
    Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid and carbohydrate metabolism in cholestyramine-fed rats.
    Meijer GW; Beynen AC
    Artery; 1989; 16(5):286-92. PubMed ID: 2764732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of bile acid synthesis by cholesterol and cholestyramine feeding is unimpaired in mice deficient in apolipoprotein AI.
    Jolley CD; Dietschy JM; Turley SD
    Hepatology; 2000 Dec; 32(6):1309-16. PubMed ID: 11093738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters.
    Li GS; Liu XH; Zhu H; Huang L; Liu YL; Ma CM; Qin C
    Biol Pharm Bull; 2011; 34(5):644-54. PubMed ID: 21532151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.
    Maugeais C; Annema W; Blum D; Mary JL; Tietge UJ
    Atherosclerosis; 2013 Jul; 229(1):94-101. PubMed ID: 23725986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal bile acid excretion and liver cholesterol synthesis after sucralfate and cholestyramine administration in the rat.
    Petit D; Bonnefis MT; Infante R
    Pharmacol Res Commun; 1986 Mar; 18(3):217-26. PubMed ID: 3755242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXRα and PPARα transcriptional programs.
    Liu X; Li G; Zhu H; Huang L; Liu Y; Ma C; Qin C
    Endocr J; 2010; 57(10):881-93. PubMed ID: 20724798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid improves insulin sensitivity and hepatic steatosis by inducing the excretion of hepatic lipids in high-fat diet-fed KK-Ay mice.
    Tsuchida T; Shiraishi M; Ohta T; Sakai K; Ishii S
    Metabolism; 2012 Jul; 61(7):944-53. PubMed ID: 22154323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.